VitaPath Genetics

VitaPath develops and performs genomic-based tests to determine an individual's need for targeted therapy in certain medical conditions treatable with vitamins. Using our platform, we are leading the exploration of the Vitanome, the subset of information that lies within our genomes that plays a critical role in how we metabolize vitamins, and the commercialization of specific assays that test vitamin-remediable genetic variants. VitaPath's genetic tests are performed by highly skilled professionals in our CLIA-certified, CAP-accredited Clinical Laboratory. Our mission is to explore the genetic variation associated with vitamin-responsive genes and to understand their influence on key metabolic pathways and processes. With this knowledge, VitaPath can develop genetic tests to identify individuals whose vitamin genetics put them at increased risk for serious medical conditions. VitaPath is a venture-backed start-up located in Silicon Valley. The company was founded in 2009 based on pioneering research by Drs. Jasper Rine and Nicholas Marini, and which has been exclusively licensed from the University of California, Berkeley.